The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...

Getting access to popular weight loss drugs will be simpler and cheaper for some.Health insurer Cigna (CI) announced a new ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Investing.com — 周四，Truist Securities维持对Hims & Hers Health Inc. (NYSE: HIMS )的持有评级，目标价为45.00美元。Truist的分析师就Evernorth最近关于减肥药物保险覆盖的公告进行了评论。Evernorth是信诺公司 (Cigna Corporation, ...

Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...

Investing.com — 周四，花旗分析师Daniel Grosslight重申了对Hims and Hers Health Inc. (NYSE: HIMS )股票的卖出评级，目标价为30.00美元。根据 InvestingPro ...

Cigna is reducing monthly out-of-pocket costs to $200 for patients using weight-loss drugs Wegovy and Zepbound. These ...